Abstract
CAVEI recommends the incorporation of conjugated meningococcal vaccine with coverage for serotype W from two months of age in a dose scheme of 2 + 1 to achieve the group's direct protection to the most vulnerable, despite having low Endemia at the national level.
Recommendation
Americas
Chile
Meningococcal disease
